Hunan Fangsheng Pharmaceutical Co Ltd (603998)

Currency in CNY
10.36
+0.10(+0.97%)
Closed·
High dividend Yield
603998 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.2510.41
52 wk Range
8.6413.50
Key Statistics
Bid/Ask
10.35 / 10.36
Prev. Close
10.36
Open
10.25
Day's Range
10.25-10.41
52 wk Range
8.64-13.5
Volume
6.77M
Average Volume (3m)
12.78M
1-Year Change
-13.4503%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603998 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
15.81
Upside
+52.61%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 15.81
(+52.61% Upside)

Earnings

Latest Release
Aug 29, 2026
EPS / Forecast
0.25 / --
Revenue / Forecast
492.5M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.76%
Dividend Yield
4.83%
Industry Median 1.75%
Annualized payout
0.50
Paid annually
5-Years Growth
+42.29%
Growth Streak

603998 Income Statement

Compare 603998 to Peers and Sector

Metrics to compare
603998
Peers
Sector
Relationship
P/E Ratio
13.6x29.1x−0.3x
PEG Ratio
0.79−0.710.00
Price/Book
2.6x2.6x2.6x
Price / LTM Sales
2.4x2.8x3.0x
Upside (Analyst Target)
52.6%29.4%56.4%
Fair Value Upside
Unlock13.2%7.2%Unlock

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China. The company offers pharmaceutical manufacturing; and provides cardiovascular and cerebrovascular drugs, skeletal muscle system drugs, orthopedic drugs, respiratory drugs, pediatric drugs, neurological drugs, gynecological drugs, and anti-infective drugs. Its products include Xuesaitong dispersible tablets; Xuesaitong tablets; Garcinia Cambogia bone strengthening tablets; Lysine Vitamin B12 granules; Cephalosporin tablets, Jinying capsules; Pudilan anti-inflammatory tablets; Tenghuang Jian Gu tablets; Xiaoer Jingxing Zhike granules; Yizhemaibu tablets; Xuanqi Jian tablets; Xuanqi Jian Gu tablets, Qiangli Pipa Gao, strong loquat syrup, and others. Hunan Fangsheng Pharmaceutical Co., Ltd. was founded in 2000 and is based in Changsha, China.

Employees
1868
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
71.06M16.18%736.15M
Other Institutional Investors
17.68M4.03%183.18M
Public Companies & Retail Investors
350.34M79.79%3.63B
Total
439.08M100.00%4.55B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rongtong Fund Management Co. Ltd.3.77%16,554,100171,500
Rongtong Health Industry Flexible Allocation Mixed Fund2.34%10,254,100106,232

People Also Watch

36.26
600105
-2.00%
22.56
600961
-0.13%
31.13
600522
-0.64%
16.120
600397
+1.13%
26.39
600580
+1.66%

FAQ

What Is the Fangsheng Pham (603998) Stock Price Today?

The Fangsheng Pham stock price today is 10.36 CNY.

What Stock Exchange Does Fangsheng Pham Trade On?

Fangsheng Pham is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Fangsheng Pham?

The stock symbol for Fangsheng Pham is "603998."

Does Fangsheng Pham Pay Dividends? What’s The Current Dividend Yield?

The Fangsheng Pham dividend yield is 4.83%.

What Is the Fangsheng Pham Market Cap?

As of today, Fangsheng Pham market cap is 4.55B CNY.

What Is Fangsheng Pham's Earnings Per Share (TTM)?

The Fangsheng Pham EPS (TTM) is 0.76.

When Is the Next Fangsheng Pham Earnings Date?

Fangsheng Pham will release its next earnings report on Oct 29, 2026.

From a Technical Analysis Perspective, Is 603998 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Fangsheng Pham Stock Split?

Fangsheng Pham has split 2 times.

How Many Employees Does Fangsheng Pham Have?

Fangsheng Pham has 1868 employees.

What is the current trading status of Fangsheng Pham (603998)?

As of Oct 01, 2026, Fangsheng Pham (603998) is trading at a price of 10.36 CNY, with a previous close of 10.36 CNY. The stock has fluctuated within a day range of 10.25 CNY to 10.41 CNY, while its 52-week range spans from 8.64 CNY to 13.50 CNY.

What Is Fangsheng Pham (603998) Price Target According to Analysts?

The average 12-month price target for Fangsheng Pham is 15.81 CNY, with a high estimate of 15.81 CNY and a low estimate of 15.81 CNY. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +52.61% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.